Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

L-Carnitine and Reduced Triglyceride Levels

Research synthesisModerate evidenceSmall effect8 studies · 5 beneficial · 3 neutral · 0 harmful

Across 8 studies, 5 reported beneficial effects of L-carnitine on reducing triglyceride levels, with effect sizes predominantly small. Benefits were most consistently observed in clinical populations such as women with PCOS and adults with metabolic conditions, with median study duration of 70 days. The most commonly effective dose ranged from 1000–3000 mg/day.

  • Effective dose range: 1000-3000 mg/day
  • Studied populations: women with PCOS, adults with impaired glucose tolerance or diabetes, hemodialysis patients

Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Benefits were observed primarily in clinical populations, so generalizability to healthy individuals is uncertain.

Generated Jul 15, 2026
Doses used in studies
  • L-Carnitine · mg/day: 3,000 (median 3,000, IQR 3,0003,000) 1 study
  • g/day: 2 (median 2, IQR 22) 1 study
  • mg/day: 1,000 (median 1,000, IQR 1,0001,000) 1 study
  • mg/kg/day: 50 (median 50, IQR 5050) 1 study
Time to effect
Median: 10 weeks · IQR 8 weeks11 weeks · Range 6 weeks2.8 months — Reported in 3 of 8 studies
8 of 8 papers
Back to top